Frank Pallone, Jr.

More on Mylan's EpiPen profiteering: It allegedly ripped off Medicaid too

More on Mylan's EpiPen profiteering: It allegedly ripped off Medicaid too

Very quietly, on the Friday before a long federal holiday weekend, Mylan last week paid $465 million to stifle government allegations that it had systematically overcharged Medicaid for its notorious EpiPen medical device.

This sum is, amazingly, well more than twice the $185 million paid by Wells Fargo over charges that its bankers systematically ripped off and stole the identities of their clients, but it hasn’t received an iota of the attention of the Wells scandal. Let’s redress the balance just a bit.

You...

57°